Debunking Common Myths About Clinical Trials

By Craig Morgan

For much of the public, drug development is shrouded in mystery.

When it comes to clinical trials in particular, myths are common. From the view that clinical trials are dangerous, to the idea that participants don’t know the details of a trial or the treatments they might take, false notions persist.

For an industry so openly regulated, monitored, and reviewed, it’s ironic that public perception of clinical trials is often disconnected from reality.

Yet inaccurate perceptions about clinical trials have the real potential to inhibit participation and the development of new drugs.